Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Paulina Velasquez

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Transplantation and Cellular Therapy|March 1, 2023
Allogeneic CD7-CAR T cells to bridge the gap?M Paulina Velasquez
Blood Cancer Discovery|January 11, 2022
Employing Synthetic T-cell Biology to Target AML without On-Target/Off-Cancer ToxicityM Paulina Velasquez, Stephen Gottschalk
Blood|July 28, 2022
CD7 CAR: sword and shieldM Paulina Velasquez, Maksim Mamonkin
Haematologica|June 4, 2024
Chimeric antigen receptor T-cell therapy in childhood acute myeloid leukemia: how far are we from a clinical application?Swati Naik, M Paulina Velasquez, Stephen Gottschalk
Frontiers in Oncology|March 19, 2020
A Bump in the Road: How the Hostile AML Microenvironment Affects CAR T Cell TherapyRebecca Epperly, Stephen Gottschalk, M Paulina Velasquez
Frontiers in Immunology|April 11, 2022
Leukemia's Next Top Model? Syngeneic Models to Advance Adoptive Cellular TherapyJaquelyn T Zoine, Sarah E Moore, M Paulina Velasquez
Pediatric Blood & Cancer|July 29, 2009
Erythrocytapheresis in children with sickle cell disease and acute chest syndromeM Paulina Velasquez, Mary M Mariscalco, Stuart L Goldstein, et al.
Haematologica|July 28, 2022
Improving the anti-acute myeloid leukemia activity of CD123-specific engager T cells by MyD88 and CD40 costimulationAbishek Vaidya, Erin Doherty, Xiya Wu, et al.
STAR Protocols|November 3, 2024
Protocol for live-cell imaging of immune synapse formation and activation of CAR T cells against cancer cellsJorge Ibanez, Nikhil Hebbar, Unmesha Thanekar, et al.
Cell Reports. Medicine|November 22, 2023
GRP78-CAR T cell effector function against solid and brain tumors is controlled by GRP78 expression on T cellsJorge Ibanez, Nikhil Hebbar, Unmesha Thanekar, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Transplantation and Cellular Therapy|March 1, 2023
Allogeneic CD7-CAR T cells to bridge the gap?M Paulina Velasquez
Blood Cancer Discovery|January 11, 2022
Employing Synthetic T-cell Biology to Target AML without On-Target/Off-Cancer ToxicityM Paulina Velasquez, Stephen Gottschalk
Blood|July 28, 2022
CD7 CAR: sword and shieldM Paulina Velasquez, Maksim Mamonkin
Haematologica|June 4, 2024
Chimeric antigen receptor T-cell therapy in childhood acute myeloid leukemia: how far are we from a clinical application?Swati Naik, M Paulina Velasquez, Stephen Gottschalk
Frontiers in Oncology|March 19, 2020
A Bump in the Road: How the Hostile AML Microenvironment Affects CAR T Cell TherapyRebecca Epperly, Stephen Gottschalk, M Paulina Velasquez
Frontiers in Immunology|April 11, 2022
Leukemia's Next Top Model? Syngeneic Models to Advance Adoptive Cellular TherapyJaquelyn T Zoine, Sarah E Moore, M Paulina Velasquez
Pediatric Blood & Cancer|July 29, 2009
Erythrocytapheresis in children with sickle cell disease and acute chest syndromeM Paulina Velasquez, Mary M Mariscalco, Stuart L Goldstein, et al.
Haematologica|July 28, 2022
Improving the anti-acute myeloid leukemia activity of CD123-specific engager T cells by MyD88 and CD40 costimulationAbishek Vaidya, Erin Doherty, Xiya Wu, et al.
STAR Protocols|November 3, 2024
Protocol for live-cell imaging of immune synapse formation and activation of CAR T cells against cancer cellsJorge Ibanez, Nikhil Hebbar, Unmesha Thanekar, et al.
Cell Reports. Medicine|November 22, 2023
GRP78-CAR T cell effector function against solid and brain tumors is controlled by GRP78 expression on T cellsJorge Ibanez, Nikhil Hebbar, Unmesha Thanekar, et al.
Pageof 3